Trillium Asset Management LLC Invests $21.92 Million in Danaher Corporation $DHR

Trillium Asset Management LLC acquired a new stake in Danaher Corporation (NYSE:DHR) in the second quarter, HoldingsChannel reports. The firm acquired 30,443 shares of the conglomerate’s stock, valued at approximately $21,923,000.

Other institutional investors and hedge funds have also modified their holdings of the company. BlackRock Inc. purchased a new position in shares of Danaher during the 2nd quarter worth $10,492,520,000. State Street Corp boosted its holdings in shares of Danaher by 1.7% during the fourth quarter. State Street Corp now owns 27,681,334 shares of the conglomerate’s stock worth $6,345,529,000 after purchasing an additional 472,608 shares during the last quarter. Capital International Investors grew its position in shares of Danaher by 8.9% in the fourth quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock valued at $4,177,386,000 after purchasing an additional 1,487,768 shares during the period. Price T Rowe Associates Inc. MD grew its position in shares of Danaher by 9.1% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 15,973,240 shares of the conglomerate’s stock valued at $3,656,595,000 after purchasing an additional 1,334,221 shares during the period. Finally, Wellington Management Group LLP increased its stake in Danaher by 11.2% in the fourth quarter. Wellington Management Group LLP now owns 15,076,796 shares of the conglomerate’s stock valued at $3,451,380,000 after purchasing an additional 1,517,904 shares during the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Analyst Ratings Changes

Several equities analysts recently weighed in on DHR shares. Evercore reiterated an “outperform” rating and set a $230.00 target price on shares of Danaher in a research report on Monday, July 6th. Argus lowered their price target on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a report on Friday, April 24th. Piper Sandler began coverage on shares of Danaher in a research note on Thursday, June 11th. They set a “neutral” rating and a $200.00 price objective for the company. Wall Street Zen lowered shares of Danaher from a “buy” rating to a “hold” rating in a report on Saturday, April 25th. Finally, TD Cowen lowered their target price on shares of Danaher from $240.00 to $236.00 and set a “buy” rating for the company in a report on Wednesday, July 22nd. One research analyst has rated the stock with a Strong Buy rating, nineteen have given a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $228.91.

Danaher Trading Up 2.2%

Shares of DHR stock opened at $216.14 on Friday. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The firm’s 50 day moving average price is $195.01 and its two-hundred day moving average price is $192.43. The stock has a market cap of $151.94 billion, a price-to-earnings ratio of 38.39, a price-to-earnings-growth ratio of 2.63 and a beta of 0.78.

Danaher (NYSE:DHR) last released its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.85 by $0.09. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The company had revenue of $6.26 billion during the quarter, compared to analyst estimates of $6.12 billion. During the same quarter in the prior year, the business earned $0.77 earnings per share. The business’s quarterly revenue was up 5.5% compared to the same quarter last year. On average, analysts anticipate that Danaher Corporation will post 8.53 EPS for the current year.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.